Latest News
Latest News
New COVID-19 Vaccines That Target KP.2 Variant Available
Two mRNA vaccines target the KP.2 variant, while a third vaccine targets the JN.1 variant, a predecessor to KP.2.
Latest News
Why More Doctors Are Joining Unions
As more physicians work for large medical groups or hospital systems, unions have become more popular.
Feature
KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?
A pipeline of KRAS inhibitors targeting pancreatic cancer has emerged.
Conference Coverage
Ivonescimab: Possible New First-Line Standard in PD-L1–Positive Advanced NSCLC?
The results highlight ivonescimab’s potential to become a ‘new standard of care’ in advanced PD-L1–positive advanced NSCLC, according to an author...
Conference Coverage
Could Aspirin Avert Bad Outcomes in Leukemia?
A preliminary study finds that aspirin reduces the length and cost of hospital stays in patients with leukemia.
Latest News
Wait, a Health Worker Surplus? Workforce Report Projects Big Surprises
New report predicts an influx of home health aides, registered nurses, and doctors, the latter in midwest states.
Feature
Should All Patients With Early Breast Cancer Receive Adjuvant Radiotherapy?
Researchers analyzed data from 589 patients with early breast cancer who were randomized to receive either high-dose or no radiotherapy.
From the Journals
High Breast Cancer Risk With Menopausal Hormone Therapy & Strong Family History
A modeling study integrated a data set of women with age-specific breast cancer risk with family history and another that covers relative risk for...
From the Journals
Breast Cancer Hormone Therapy May Protect Against Dementia
Researchers identified more than 18,000 women with breast cancer who did and did not receive hormone-modulating therapy within 3 years of their...
From the Journals
False-Positive Mammography Results Linked to Reduced Rates of Future Screenings
Researchers analyzed more than three million screening mammograms from more than 1 million women.
Conference Coverage
To Choose the Best First-line Drug for CML, Consider Efficacy and Cost
For treatment value, imatinib remains the CML gold standard: a generic, second-generation TKI that helps improve treatment-free remission rates....